Delivery Order SPE2DB22D3301-SPE2DB25FY4UF

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,819.76 firm fixed-price delivery order is for the supply of 4,567,957,155 units of Lidocaine 5% Patch 30s. The contract has an ultimate completion date of April 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,937.47 firm fixed-price delivery order is for the supply of 4560957153 - Lidocaine 5% Patch 30s, with a completion date of May 17, 2023. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,176.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568249854 - Lidocaine 5% Patch 30s, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 15, 2025. The contract is not set aside and is open to full and open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,496.57 contract is for the delivery of Lidocaine 5% patches and has a performance period ending on May 8, 2025. The award is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,018.88 firm fixed-price delivery order is for the supply of 4561169856 - Lidocaine 5% Patch 30s. The contract has an ultimate completion date of June 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,514.89 Firm Fixed Price Delivery Order is for the supply of 4,568,227,228 units of Lidocaine 5% Patch 30s, with a performance period through May 14, 2025. The award is not set-aside and represents an open competition contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,118.28 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches, with a period of performance through June 6, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,213.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567944152 - Lidocaine 5% Patch 30s. The contract has an ultimate completion date of April 17, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,046.07 firm-fixed-price delivery order is for the supply of 4564793387 - Lidocaine 5% Patch 30s, with a period of performance through June 4, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,583.38 firm-fixed-price delivery order is for the provision of 4566088364 - Lidocaine 5% Patches. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY4UF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,151.36 firm fixed-price delivery order is for the supply of 4568236581 Lidocaine 5% Patch 30S, with a performance period through May 14, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 11:52 AM